Economic Evaluation Techniques in Healthcare Alan Maynard Current Opinion 01 December 2012 Pages: 115 - 118
The Role of the US Food and Drug Administration’s Patient Information Initiative in Cost-Effective Drug Therapy Stuart NightingaleThomas J. McGinnis Leading Article 01 December 2012 Pages: 119 - 125
The Economics of Osteoporosis and Its Prevention David J. TorgersonDavid M. Reid Review Article 01 December 2012 Pages: 126 - 138
Erratum to A case for the adoption of pharmacoeconomic guidelines in Japan Ikeda Erratum 01 December 2012 Pages: 138 - 138
The Economics of Pharmacotherapy for Diabetes Mellitus Bernardo CostaJaume ArroyoAngels Sabaté Review Article 01 December 2012 Pages: 139 - 158
Guidelines for Pharmacoeconomic Studies Joanna E. SiegelGeorge W. Torrancethe members of the Panel on Cost Effectiveness in Health and Medicine Special Article 01 December 2012 Pages: 159 - 168
An Economic Evaluation of the Use of Granulocyte Colony-Stimulating Factor After Bone Marrow Transplantation in Children Nicholas DuncanMargaret HewetsonRoss Pinkerton Original Research Article 01 December 2012 Pages: 169 - 174
Differences in the Methodology and Data of Economic Evaluations of a Health Programme Xavier BadiaGonzalo NoceaJoan Rovira Original Research Article 01 December 2012 Pages: 175 - 183
Terazosin Greg L. PloskerKaren L. Goa Adis Pharmacoeconomic Drug Evaluation 01 December 2012 Pages: 184 - 197